Otsuka at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Otsuka takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on embryofetal development studies, which check whether a drug harms a developing fetus, and offers a modern guide to running them, starting from the basics.

OrganizationACT 2026 Attendance
Otsuka
Tokyo, Japan
otsuka.co.jp
Pharmaceutical companies
Japanese pharmaceutical company; its nonclinical safety team chairs a course on embryofetal development testing.
Talk
Sun Nov 15
8:00am–8:05am
Part of The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3)
The ABCs of EFDs Introduction (CE3-1)
DART
Session
Sun Nov 15
8:00am–11:30am
The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3)
DART · with Sanofi
  1. 8:00amThe ABCs of EFDs Introduction (CE3-1)Otsuka
  2. 8:05amDesigning a EFD Study (CE3-2)Amgen
  3. 8:30amSetting the EFD Testing Study Strategy (CE3-3)Sanofi
  4. 9:00amConducting an EFD Study: The Essentials of Getting it Right (CE3-4)Johnson & Johnson
  5. 10:00amInterpreting EFD Study Data (CE3-5)Lilly
  6. 10:35amCommunicating EFD Study Results (CE3-6)

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Otsuka

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction